Recent Finacing
Recent Raise
Raziel Therapeutics is a clinical-stage biopharma developing RZL-012, a single-injection new chemical entity for subcutaneous fat reduction and treatment of Dercum’s disease, with FDA orphan designation.
Recent Investors
Total Raised
Funding round
Investors
